BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 619948)

  • 1. A comparison of some physiological and psychological effects of Motival (fluphenazine and nortriptyline) and diazepam in normal subjects.
    Ashton H; Millman JE; Telford R; Thompson JW
    Br J Clin Pharmacol; 1978 Feb; 5(2):141-7. PubMed ID: 619948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of some physiological and psychological effects of propranolol and diazepam in normal subjects.
    Ashton H; Millman JE; Telford R; Thompson JW
    Br J Clin Pharmacol; 1976 Aug; 3(4):551-9. PubMed ID: 22216493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies of fluphenazine and nortriptyline in combination in man.
    Glegg AM; Turner P
    J Pharm Pharmacol; 1971 Feb; 23(2):133-4. PubMed ID: 4396873
    [No Abstract]   [Full Text] [Related]  

  • 4. A review of clinical studies with combinations of fluphenazine and nortriptyline.
    Pigott PV
    Curr Med Res Opin; 1972; 1(1):26-36. PubMed ID: 4589400
    [No Abstract]   [Full Text] [Related]  

  • 5. Separate and combined anxiolytic and anti-depressant treatment of mixed anxiety/depression. A double-blind, placebo controlled comparison. Sussex Clinical Trials Group.
    Acta Psychiatr Scand; 1985 Jul; 72(1):81-8. PubMed ID: 2863922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluphenazine/nortriptyline in the irritable bladder syndrome. A double-blind placebo controlled study.
    Martin MR; Schiff AA
    Br J Urol; 1984 Apr; 56(2):178-9. PubMed ID: 6388713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once daily administration of a fluphenazine/nortriptyline preparation in the treatment of mixed anxiety/depressive states.
    Brodie NH; McGhie RL; O'Hara H; O'Hara J; Rodway AE; Valle-Jones JC; Schiff AA
    Curr Med Res Opin; 1976; 4(5):346-52. PubMed ID: 795608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality traits influence the effects of diazepam and caffeine on CNV magnitude.
    Münte TF; Heinze HJ; Künkel H; Scholz M
    Neuropsychobiology; 1984; 12(1):60-7. PubMed ID: 6514179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motival in the treatment of anxiety, with or without depression.
    Grozier ML
    Psychosomatics; 1972; 13(2):109-16. PubMed ID: 4604794
    [No Abstract]   [Full Text] [Related]  

  • 10. Once-daily treatment for mixed anxiety/depressive states: a comparison of slow release amitriptyline and fluphenazine with nortriptyline.
    Magnus RV; Schiff AA
    J Int Med Res; 1977; 5(2):109-13. PubMed ID: 873028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of anxiety/depressive conditions in the elderly: a double-blind comparative study of Motival and amitriptyline.
    Sinclair JM; Walsh MR; Valle-Jones JC; Schiff AA
    Age Ageing; 1975 Nov; 4(4):226-31. PubMed ID: 803187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of fluphenazine with nortriptyline in anxiety and depression.
    Anderson J; Lambert NG; Pigott PV
    Practitioner; 1972 Apr; 208(246):511-7. PubMed ID: 4555519
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of amitriptyline and a fluphenazine/nortriptyline preparation in anxiety-depressive states.
    Bennie EH; Schiff AA
    Scott Med J; 1976 Oct; 21(4):204-9. PubMed ID: 793005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of diazepam, chlorpromazine and amobarbital on the contingent negative variation.
    Kuda K
    Folia Psychiatr Neurol Jpn; 1977; 31(1):77-87. PubMed ID: 558950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elamol and Motival-new psychotropic drugs?
    Drug Ther Bull; 1972 Oct; 10(21):83-4. PubMed ID: 4656671
    [No Abstract]   [Full Text] [Related]  

  • 16. Motival in the treatment of anxious depression.
    Faleni R; Cia A
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):461-9. PubMed ID: 4629308
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical and physiological assessment of chlorazepate, diazepam and placebo in anxious neurotics.
    Lapierre YD
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):315-22. PubMed ID: 239907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A test of the concept of "underlying depressive illness" in the treatment of anxiety states.
    Walsh MR; Dunckley HG; Sinclair JM; Schiff AA
    Curr Med Res Opin; 1976; 4(5):340-5. PubMed ID: 12915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doctor's versus patient's judgement in the assessment of mixed anxiety/depressive illness. Implications for measurement of therapeutic response.
    Valle-Jones JC; O'Hara J; O'Hara H; McGhie RL; Brodie NH; Anderson JA; Schiff AA
    Acta Psychiatr Scand; 1981 May; 63(5):416-24. PubMed ID: 7032221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of unstable detrusor (irritable bladder) using fluphenazine and nortriptyline: progress report.
    Martin MR; James ED
    Prog Clin Biol Res; 1981; 78():335-8. PubMed ID: 7038710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.